Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
Beer hops compounds could help protect against Alzheimer’s disease
Beer is one of the oldest and most popular beverages in the world, with some people loving and others hating the distinct, bitter taste of the hops used to flavor its many varieties. But an especially “hoppy” brew might have unique health benefits. Recent research published in ACS Chemical Neuroscience reports that chemicals extracted from hop flowers can, in lab dishes, inhibit the clumping of amyloid beta proteins, which is associated with Alzheimer’s disease (AD).
AD is a debilitating neurodegenerative disease, often marked by memory loss and personality changes in older adults. Part of the difficulty in treating the disease is the time lag between the start of underlying biochemical processes and the onset of symptoms, with several years separating them. This means that irreversible damage to the nervous system occurs before one even realizes they may have the disease. Accordingly, preventative strategies and therapeutics that can intervene before symptoms appear are of increasing interest.
One of these strategies involves “nutraceuticals,” or foods that have some type of medicinal or nutritional function. The hop flowers used to flavor beers have been explored as one of these potential nutraceuticals, with previous studies suggesting that the plant could interfere with the accumulation of amyloid beta proteins associated with AD. So, Cristina Airoldi, Alessandro Palmioli and colleagues wanted to investigate which chemical compounds in hops had this effect.
To identify these compounds, the researchers created and characterized extracts of four common varieties of hops using a method similar to that used in the brewing process. In tests, they found that the extracts had antioxidant properties and could prevent amyloid beta proteins from clumping in human nerve cells. The most successful extract was from the Tettnang hop, found in many types of lagers and lighter ales. When that extract was separated into fractions, the one containing a high level of polyphenols showed the most potent antibiotic and aggregation-inhibiting activity. It also promoted processes that allow the body to clear out misfolded, neurotoxic proteins. Finally, the team tested the Tettnang extract in a C. elegans model and found that it protected the worms from AD-related paralysis, though the effect was not very pronounced. The researchers say that although this work may not justify drinking more bitter brews, it shows that hop compounds could serve as the basis for nutraceuticals that combat the development of AD.
- amyloid beta
- American Chemical Society
- 1How old is your brain, really?
- 2How COVID-19 permanently damages the heart
- 3Six minutes of high-intensity exercise could delay the onset of Alzheimer’s disease
- 4Sweet salvation - how a sugar cane pathogen is gearing up a new era of antibiotic discovery
- 5Simply resolving inflammation through the flick of a switch
- 6Green tea and resveratrol reduce Alzheimer's plaques in lab tests
- 7Microbe of the Year 2023: Bacillus subtilis – for health and technology
- 8Five childhood risk factors predict heart attacks and strokes in adulthood
- 9Artificial DNA kills cancer
- 10A promising drug delivery method could replace injections with pills
- Why older fathers pass on more genetic mutations to their offspring
- Chemists are first to synthesize ocean-based molecule that could fight Parkinson’s
- In cells, UV-emitting nail polish dryers damage DNA and cause mutations
- Nanotechnology may improve gene therapy for blindness
- New high-tech startup developing smart contact lenses for glaucoma diagnosis and management